Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio Key International (BKYI) Payables (2016 - 2025)

Bio Key International's Payables history spans 16 years, with the latest figure at $975481.0 for Q3 2025.

  • For Q3 2025, Payables fell 37.66% year-over-year to $975481.0; the TTM value through Sep 2025 reached $975481.0, down 37.66%, while the annual FY2024 figure was $2.3 million, 78.13% up from the prior year.
  • Payables for Q3 2025 was $975481.0 at Bio Key International, up from $889026.0 in the prior quarter.
  • Across five years, Payables topped out at $4.4 million in Q2 2023 and bottomed at $309323.0 in Q1 2021.
  • The 5-year median for Payables is $1.3 million (2022), against an average of $1.7 million.
  • The largest annual shift saw Payables plummeted 89.4% in 2021 before it skyrocketed 765.99% in 2022.
  • A 5-year view of Payables shows it stood at $427772.0 in 2021, then surged by 765.99% to $3.7 million in 2022, then tumbled by 64.48% to $1.3 million in 2023, then surged by 78.13% to $2.3 million in 2024, then plummeted by 58.39% to $975481.0 in 2025.
  • Per Business Quant, the three most recent readings for BKYI's Payables are $975481.0 (Q3 2025), $889026.0 (Q2 2025), and $568836.0 (Q1 2025).